Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2
Objective Cardiovascular risk estimation is an essential step to reduce the onset of adverse cardiovascular events. For this purpose, the Systematic Coronary Risk Evaluation (SCORE) risk chart method was used in Europe. In 2021, the SCORE2 algorithm was released, bringing changes in the calculation...
Main Authors: | Peter Andreka, Orsolya Csenteri, Zoltán Jancsó, Gergő József Szöllösi, Péter Vajer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-08-01
|
Series: | Open Heart |
Online Access: | https://openheart.bmj.com/content/9/2/e002087.full |
Similar Items
-
Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary
by: Zoltán Jancsó, et al.
Published: (2022-11-01) -
Differences between SCORE, Framingham Risk Score, and Estimated Pulse Wave Velocity-Based Vascular Age Calculation Methods Based on Data from the Three Generations Health Program in Hungary
by: Helga Gyöngyösi, et al.
Published: (2023-12-01) -
External validation of the GRACE risk score in patients with myocardial infarction in Hungary
by: Tamás Ferenci, et al.
Published: (2023-06-01) -
Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments
by: George B. Busby, et al.
Published: (2023-11-01) -
Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients-Dynamically hyperinflated and non-hyperinflated subgroups.
by: Jozsef Lukacsovits, et al.
Published: (2023-01-01)